Pharmacokinetics/Pharmacodynamics Core
Pharmacokinetics/Pharmacodynamics Core
批准号:
10609947
负责人:
Steven Shafer
金额:
$8.27万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-04-15 至 2027-03-31
关键词:
AcuteAcute PainAgeAnimalsBehaviorBloodBlood - brain barrier anatomyBlood specimenBrainCentral Nervous SystemClinicalClinical TrialsCollaborationsComplexDataDiseaseDoseDrug KineticsEnsureEquationGoalsHumanInjuryIntramuscularKineticsMeasurementMeasuresModelingModificationNervous SystemNociceptionOperative Surgical ProceduresOutcome MeasureOxytocinPainPain MeasurementPatient CarePeripheralPharmaceutical PreparationsPharmacodynamicsPlasmaRattusRecoveryRegimenReproducibilityResearchResearch PersonnelRoleRouteSensorySerumSiteSpeedTherapeuticTimeTissuesTranslationsWeightWorkchronic painclinical effectclinical translationdesigndrug actionhealinghuman subjectmathematical modelneurophysiologypain reductionpharmacodynamic modelpharmacokinetic modelpharmacokinetics and pharmacodynamicspharmacologicprogramsresponsesexsubcutaneoustissue injuryuptake
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PK/PD Core Summary
The overall aims of this integrated P01 proposal are to advance fundamental understanding and
provide clinical translation of oxytocin’s actions in the periphery and in the central nervous system as they
relate to sensory processing and recovery from tissue injury, including surgery.
The three goals of this program project are 1) to determine oxytocin pharmacokinetics (relationship
between dose and concentration) and pharmacodynamics (relationship between concentration and drug effect)
in rats and humans, 2) characterize the mechanisms of oxytocin actions on acute pain and sensitization at
peripheral and central sites, and 3) determine the central and peripheral actions of oxytocin on recovery after
tissue injury (e.g., surgery). Each of these goals is predicated on precise measurement of oxytocin dose and
concentration, construction of mathematical models relating blood oxytocin concentration to oxytocin dose and
route of delivery, and construction of mathematical models relating oxytocin concentration to drug effect. The
first goal comprises measuring oxytocin dose, concentration, and effect, and developing mathematical models
of these fundamental relationships. This is the critical analysis that brings new scientific rigor to the second and
third aims, because we will use the pharmacokinetic and pharmacodynamic models to give oxytocin in a
manner that facilitates rigorous exploration of the dose – concentration – drug response relationship for both
acute pain and sensitization (goal 2) and speed of recovery (goal 3) for both peripheral and central sites
(differentiated by leveraging differences in peripheral and central pharmacokinetics to target each site
experimentally).
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Pharmacokinetics/Pharmacodynamics Core
-
批准号:10332262
-
项目类别:
-
资助金额:$33.3万
-
财政年份:2022
-
负责人:Steven Shafer
-
依托单位:
海外基金